Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Alberti (Buenos Aires, Argentina), M. Fernandez (Buenos Aires, Argentina), L. Fassola (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), F. Paulin (Buenos Aires, Argentina). Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.. 2969

Member's Comments

No comment yet.

Related content which might interest you: Retrospective analysis of microbiome in idiopathic pulmonary fibrosis. Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 Retrospective evaluation of our cohort of patients with chronic estrinsic allergic alveolitis. Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study Source: Eur Respir J 2012; 40: 101-109 Year: 2012 Retrospective study on the treatment and prognosis of acute exacerbation of idiopathic pulmonary fibrosis in Japan Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Clinical pattern of idiopathic pulmonary fibrosis in Iran: A retrospective study Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Retrospective analysis of acute exacerbation in idiopathic interstitial pneumonias Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009 Retrospective studies of the association between idiopathic pulmonary fibrosis and lifestyle-related disease Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007 Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis Year: 2020 Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020 Idiopathic chronic obliterative bronchiolitis: a multicentric retrospective cohort Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Survival in idiopathic pulmonary fibrosis: results of the IFIGENIA follow up study Source: Eur Respir J 2004; 24: Suppl. 48, 254s Year: 2004 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020 Year: 2020 Emphysematous changes in chronic hypersensitivity pneumonitis: A retrospective analysis of 12 patients Source: International Congress 2016 – Orphan diseases II Year: 2016 Cluster analysis and survival in patients with Idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019 Year: 2020 Final analysis of RECAP, an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment I Year: 2016 Patterns of pulmonary hypertension in Egyptian patients with COPD: A retrospective analysis Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021